Drug Development and Clinical Trial Results: Positive outcomes in clinical trials, FDA approvals, and successful drug launches typically boost the stock price, while failures or delays can negatively impact it. Pharmaceutical Industry Trends: Overall industry growth, technological advancements, and shifts in regulatory landscapes can affect investor sentiment and AZN.ST's valuation. Competition: The emergence of new competitors or generic versions of existing drugs can decrease AZN.ST's market share and profitability, leading to price declines. Economic Conditions: Global economic downturns or recessions can reduce healthcare spending and negatively affect pharmaceutical companies' revenue and stock prices. Regulatory Changes: Changes in drug pricing regulations, patent laws, or healthcare policies can significantly impact AZN.ST's profitability and stock performance. Company Financial Performance: Revenue growth, profitability margins, earnings per share (EPS), and cash flow generation are key indicators of AZN.ST's financial health and can influence investor confidence.